VEGFA and hepatocellular carcinoma: Chesnokov et al. discovered that Vegfa isoform ratio produced by AS may be a promising factor for prediction of anti-angiogenic therapy efficiency in human hepatocellular carcinoma (Chesnokov et al., 2018).